AVR
HOLD / NEUTRALMeanRevComposite
39.40
Technical
26.30
Fundamental
43.70
Rank
—
Price
7.61
Hurst
0.09
As of
Oct 2, 2026
Daily
Anteris Technologies Global Corp.
HealthcareMedical DevicesAnteris Technologies Global Corp. develops and sells catheter-based devices for treating heart valve conditions without open surgery. Its main product is a transcatheter aortic valve designed to replace diseased valves in patients with severe aortic narrowing. The company also produces tissue processing technology that prevents calcification in biological valve materials and manufactures a specialized delivery catheter system that allows physicians to position valves precisely within the heart.
Market cap
$751.4M
P/E (trailing)
—
P/E (forward)
-7.71
PEG ratio
—
Dividend yield
—
Beta
—
52w range
3.30 – 11.06
Return on equity
-74.65%
Profit margin
0.00%
Revenue growth
+63.30%
Earnings growth
—
Price history
1Y: 7.71 (+78.9%) · range 3.38–10.57
Cycle position
30/ 100 cycle scoreAPPROACHING ENTRY
ENTRYAPPROACHMID-BULLNEAR-TOPEXIT
entry readiness 59 · MODERATE · exit proximity 0
Conviction
45/ 100 · maturity 14%
VScore.0917
Buildup.3037
EMA entry setup.3859
Fundamentals.2344
Volume profile
POC
9.53
Price vs POC
-20.1%
Overhead supply
82%
Runway
+7.4%
Value area 8.01–10.15 · 82% of 120d volume overhead · heavy supply
Contributing sources
| Source | Score | Last seen |
|---|---|---|
| insider-activity | 0.400 | Oct 2, 2026 |
Pattern & cluster
Pattern
CONTRADICTdescending_triangle:confirmed
Cluster
NEUTRALForward returns
Not yet labeled — the study prices these as positions mature.